‘Why would you promote something that is less percent safer than a condom?’: Perspectives on partially effective HIV prevention technologies among key populations in South Africa...

by Clara Rubincam, Peter A. Newman, Millicent Atujuna, Linda-Gail Bekker
Published 2018-01-01

Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.

by Millicent Atujuna, Peter A Newman, Melissa Wallace, Megan Eluhu, Clara Rubincam, Ben Brown, Linda-Gail Bekker
Published 2018-01-01

Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study.

by Peter A Newman, Clara Rubincam, Catherine Slack, Zaynab Essack, Venkatesan Chakrapani, Deng-Min Chuang, Suchon Tepjan, Murali Shunmugam, Surachet Roungprakhon, Carmen Logie, Jennifer Koen, Graham Lindegger
Published 2015-01-01